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1184 Eagleton November 2014technical ﬁles of the various subcomponents used to
assemble this PAEG. This may help shorten the regulatory
path by minimizing the amount of testing required.
Limitations of this study include its retrospective nature
and lack of a control group. Because of the small number of
patients, we were not able to perform statistical analysis.
CONCLUSIONS
There are few medical maladies that have challenged
our specialty like the management of TAAAs. The layers
of complexity of this problem continue to grow as our
treatment options expand. Historically, only a small num-
ber of patients with this problem were deemed ﬁt enough
to undergo open repair. Only a handful of centers could
generate sufﬁciently reasonable and predictable outcomes
to justify considering such an extensive repair. With the
introduction of endovascular repair, we have opened the
door to treating more patients but have not necessarily
expanded the number of centers.
There is a need for a technique that empowers physi-
cians with a safe and simple way to treat these patients
closer to home while being able to maintain predictable
outcomes. The ideal endovascular system needs to be
modular so as to be an off-the-shelf system. Its conﬁgura-
tion needs to be nonanatomically based to widen the range
of anatomic conﬁgurations that can be treated. It must also
have “surgical bailouts” that allow the surgeon to be able
to stop the procedure at any point in the case while not
leaving the patient with compromised perfusion to any or-
gan system. We think that this approach, which makes use
of delayed distal seal, does this. It simpliﬁes case planning
by requiring only one measurement to be made in the
proximal seal zone; it can be used in an off-the-shelf way,
and it can accommodate a large variety of anatomies.
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procedure. Semin Vasc Surg 2012;25:153-60.Submitted Feb 7, 2014; accepted May 14, 2014.INVITED COMMENTARYMatthew J. Eagleton, MD, Cleveland, OhioThe authors present a unique endovascular solution for the
treatment of thoracoabdominal aortic aneurysms (TAAA)
involving alteration and assembly of commercial endografts bythe physician. The manuscript can be added to the growing
body of literature describing “creative techniques” to provide
endovascular treatment of TAAA, which include the use of
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sandwiches as well as other direct physician modiﬁcation of com-
mercial grafts.1-3 The evolution of these techniques is sparked by
an apparent clinical need. Only one commercial fenestrated endog-
raft is available, and its use is limited by the need for customization,
a short infrarenal neck, and dissemination of physician training.
Off-the-shelf devices have reached clinical trials, but none has yet
obtained commercialization, and many have limited application
to treat extensive TAAA. Currently, outside of the creative tech-
niques, endovascular repair of TAAA requires the use of custom-
made devices (and some off-the-shelf designs) that are available
only at a few centers nationwide as part of physician-sponsored
investigational device exemption trials. Treatment in these trials
is frequently difﬁcult for patients because of the time and expense
of travel and the potential denial of insurance coverage.
Whereas creative techniques offer a potential alternative to
custom devices, many questions remain unanswered with respect
to this approach: Which patients are suitable candidates? Are the
repairs durable? Can and should these techniques be readily adapt-
ed by everyone? Can health care systems support the costs associ-
ated with use of multiple devices? Despite their shortcomings,
customized fenestrated/branched endografts have been closely
evaluated during long periods and provide a durable repair in pa-
tients who are at high risk for surgery with outcomes that rival
those of conventional operations.4-6 Outcomes are reported from
physician-sponsored investigational device exemption trials with
well-deﬁned patient and anatomic enrollment criteria with stan-
dard clinical and imaging follow-up protocols. This type of data
is lacking for any of the creative techniques. They should, however,
be held to the same standard. If creative techniques are to be
accepted as durable options, we must evolve from reportingtechniques in a few patients with limited outcomes and instead
direct efforts toward understanding patient selection, improving
graft modiﬁcation techniques, predicting those at risk for failure,
and determining whether these techniques can be readily dissemi-
nated. The ramiﬁcations of failure with endovascular TAAA repair
are great and need to be avoided. Only a well-planned assessment
of robust data will allow us to answer these questions, to assess the
modes of failure, and to determine whether these approaches are in
our patients’ best interests. Future endeavors, in an organized
fashion, are necessary to achieve these goals.
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